[Figure: see text]

2nd Faculty of Medicine Department of Pediatric Hematology and Oncology Charles University Prague Czech Republic

Childhood Leukaemia Investigation Prague Prague Czech Republic

Department of Bioenergetics Institute of Physiology of the Czech Academy of Science Prague Czech Republic

Institute of Metabolism and Systems Research College of Medical and Dental Sciences University of Birmingham Birmingham United Kingdom

Laboratory of Structural Biology and Cell Signalling Institute of Microbiology Academy of Science of the Czech Republic Prague Czech Republic

University Hospital Motol Prague Czech Republic

Blood Adv. 2023 Oct 24;7(20):6023. doi: 10.1182/bloodadvances.2023011150. PubMed

Zobrazit více v PubMed

Pui C, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354(2):166–178. PubMed

Einsiedel HG, Von Stackelberg A, Hartmann R, et al. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster group 87. J Clin Oncol. 2005;23(31):7942–7950. PubMed

Nguyen K, Devidas M, Cheng SC, et al. Factors influencing survival after relapse from acute lymphoblastic leukemia: a children’s oncology group study. Leukemia. 2008;22(12):2142–2150. PubMed PMC

Iacobucci I, Mullighan CG. Genetic basis of acute lymphoblastic leukemia. J Clin Oncol. 2017;35(9):975–983. PubMed PMC

Tabe Y, Lorenzi PL, Konopleva M. Amino acid metabolism in hematologic malignancies and the era of targeted therapy. Blood. 2019;134(13):1014–1023. PubMed PMC

Hermanova I, Arruabarrena-Aristorena A, Valis K, et al. Pharmacological inhibition of fatty-acid oxidation synergistically enhances the effect of l-asparaginase in childhood ALL cells. Leukemia. 2016;30(1):209–218. PubMed

Polak R, De Rooij B, Pieters R, den Boer ML. B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment. Blood. 2015;126(21):2404–2414. PubMed

Ede BC, Asmaro RR, Moppett JP, Diamanti P, Blair A. Investigating chemoresistance to improve sensitivity of childhood T-cell acute lymphoblastic leukemia to parthenolide. Haematologica. 2018;103(9):1493–1501. PubMed PMC

Ehsanipour EA, Sheng X, Behan JW, et al. Adipocytes cause leukemia cell resistance to l-asparaginase via release of glutamine. Cancer Res. 2013;73(10):2998–3006. PubMed PMC

Pillozzi S, Masselli M, De Lorenzo E, et al. Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers. Blood. 2011;117(3):902–914. PubMed

Sison EAR, Brown P. The bone marrow microenvironment and leukemia: biology and therapeutic targeting. Expert Rev Hematol. 2011;4(3):271–283. PubMed PMC

Ma L, Zong X. Metabolic symbiosis in chemoresistance: refocusing the role of Aerobic glycolysis. Front Oncol. 2020;10:1–8. PubMed PMC

Meyer LK, Hermiston ML. The bone marrow microenvironment as a mediator of chemoresistance in acute lymphoblastic leukemia. Cancer Drug Resist. 2019;2(4):1164–1177. PubMed PMC

Manabe A, Coustan-Smith E, Behm FG, Raimondi SC, Campana D. Bone marrow-derived stromal cells prevent apoptotic cell death in B- lineage acute lymphoblastic leukemia. Blood. 1992;79(9):2370–2377. PubMed

Iwamoto S, Mihara K, Downing JR, Pui CH, Campana D. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. J Clin Invest. 2007;117(4):1049–1057. PubMed PMC

Muz B, de la Puente P, Azab F, Azab AK. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckl) 2015;3:83–92. PubMed PMC

Fecteau JF, Messmer D, Zhang S, et al. Impact of oxygen concentration on growth of mesenchymal stromal cells from the marrow of patients with chronic lymphocytic leukemia. Blood. 2013;121(6):971–974. PubMed PMC

Adamo A, Delfino P, Gatti A, et al. HS-5 and HS-27A stromal cell lines to study bone marrow mesenchymal stromal cell-mediated support to cancer development. Front Cell Dev Biol. 2020;8 PubMed PMC

Cai J, Wang J, Huang Y, et al. ERK/Drp1-dependent mitochondrial fission is involved in the MSC-induced drug resistance of T-cell acute lymphoblastic leukemia cells. Cell Death Dis. 2016;7(11) e2459-11. PubMed PMC

Gonzalez-Manchon C, Parrilla R, Ayuso MS. Role of fatty acid in the control of protein synthesis in liver cells. Biochem Int. 1990;21(5):933–940. PubMed

Melick CH, Jewell JL. Regulation of mTORC1 by upstream stimuli. Genes (Basel) 2020;11(9):1–28. PubMed PMC

Robitaille AM, Christen S, Shimobayashi M, et al. Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis. Science. 2013;339(6125):1320–1323. PubMed

Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168(6):960–976. PubMed PMC

Krall AS, Xu S, Graeber TG, Braas D, Christofk HR. Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor. Nat Commun. 2016;7 PubMed PMC

Li J, Xue L, Hao H, et al. Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemia. Oncol Rep. 2012;27(2):461–466. PubMed

Hellsten SV, Lekholm E, Ahmad T, Fredriksson R. The gene expression of numerous SLC transporters is altered in the immortalized hypothalamic cell line N25/2 following amino acid starvation. FEBS Open Bio. 2017;7(2):249–264. PubMed PMC

Balasubramanian MN, Butterworth EA, Kilberg MS. Asparagine synthetase: regulation by cell stress and involvement in tumor biology. Am J Physiol Endocrinol Metab. 2013;304(8):E789–E799. PubMed PMC